Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the efficacy and safety of GSP 301 NS compared to placebo NS and to
individual monotherapies (comparators) as well as the efficacy of these monotherapies
(comparators) versus placebo NS over 14 days of study treatment